UNVERIFIEDSingle SourceSTAT+: Drugmakers guard IP more tightly amid China competition Stat News|5/20/2026
UNVERIFIEDSingle SourceSTAT+: A new ranking of pharma companies by R&D performance Stat News|5/19/2026
UNVERIFIEDSingle SourceSTAT+: Eli Lilly tops prominent rankings on pharma R&D performanceStat News|5/19/2026
UNVERIFIEDSingle SourceSTAT+: Supreme Court rejects challenge to Medicare drug price negotiationStat News|5/18/2026
UNVERIFIEDSingle SourceSTAT+: Up and down the ladder: The latest comings and goingsStat News|5/15/2026
UNVERIFIEDSingle SourceSTAT+: A political contest in the U.K. could shake up drug pricingStat News|5/15/2026
UNVERIFIEDSingle SourceSTAT+: Top U.S. officials pressured Germany to pay more for prescription drugsStat News|5/15/2026
UNVERIFIEDSingle SourceSTAT+: CDC plans to transfer monkeys to nonprofit’s sanctuary as it seeks to reduce animal testingStat News|5/14/2026
UNVERIFIEDSingle SourceSTAT+: Biogen’s tau-targeting Alzheimer’s drug posts mixed results in mid-stage studyStat News|5/14/2026
UNVERIFIEDSingle SourceSTAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 millionStat News|5/14/2026
UNVERIFIEDSingle SourceSTAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submissionStat News|5/14/2026
UNVERIFIEDSingle SourceSTAT+: ‘No drama’ Diamantas should serve biotech well as acting FDA chiefStat News|5/14/2026